Medical Equipment Stocks on Investors' Radar -- Align Technology, Masimo, Corindus Vascular Robotics, and Avinger

Thursday, September 21, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, September 21, 2017 /PRNewswire/ --

If you want a Stock Review on ALGN, MASI, CVRS, or AVGR then come over

to and sign up for your free customized report today. On Wednesday, September 20, 2017, US markets saw five out of nine sectors finishing the day in green and 4 in red. Major US
indices were also mixed at the close of yesterday's session. The NASDAQ Composite ended the day at 6,456.04, down 0.08%; the Dow Jones Industrial Average edged 0.19% higher, to finish at 22,412.59; and the S&P 500 closed at 2,508.24, up 0.06%. This Thursday morning, looks at the performance of these four Medical Appliances & Equipment stocks: Align Technology Inc. (NASDAQ: ALGN), Masimo Corp. (NASDAQ: MASI), Corindus Vascular Robotics Inc. (NYSE MKT: CVRS), and Avinger Inc. (NASDAQ: AVGR). This morning's free research reports on the aforesaid equities can be accessed upon registration on at:

Align Technology 

On Wednesday, shares in San Jose, California headquartered Align Technology Inc. recorded a trading volume of 565,025 shares. The stock ended the session 0.85% higher at $188.78. The Company's shares have gained 12.38% in the last month, 26.34% over the previous three months, 101.47% in the past twelve months, and 96.38% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 10.46% and 44.85%, respectively. Moreover, shares of Align Technology, which designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services, have a Relative Strength Index (RSI) of 68.07. Visit us today and download your complete report on ALGN for free at:


Irvine, California headquartered Masimo Corp.'s stock closed the day 0.49% higher at $85.77 with a total trading volume of 365,646 shares. The Company's shares have advanced 44.61% over the last twelve months and 27.26% since the start of this year. The stock is trading above its 200-day moving average by 0.39%. Additionally, shares of Masimo, which develops, manufactures, and markets noninvasive monitoring technologies worldwide, have an RSI of 43.80. The complimentary research report on MASI can be accessed at:

Corindus Vascular Robotics 

Shares in Waltham, Massachusetts headquartered Corindus Vascular Robotics Inc. recorded a trading volume of 620,934 shares. The stock ended yesterday's trading session 3.38% higher at $1.53. The Company's shares have advanced 11.68% in the past month, 30.77% in the past twelve months, and 119.07% on an YTD basis. The stock is trading above its 200-day moving average by 26.07%. Furthermore, shares of Corindus Vascular Robotics, which designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures, have an RSI of 42.11. Register for free on and download the research report on CVRS at:


Redwood City, California headquartered Avinger Inc.'s stock finished Wednesday's session 2.20% lower at $0.24 with a total trading volume of 281,177 shares. The stock is trading below its 50-day moving average by 33.55%. Additionally, shares of Avinger, which designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease in the US and Europe, have an RSI of 30.48. Get free access to your research report on AVGR at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store